What are the means of percutaneous interventional treatment for liver cancer? There are three therapies

Generally speaking, the methods of percutaneous interventional treatment for liver cancer include: minimally invasive skin radiofrequency ablation therapy, thermal perfusion therapy combining chemotherapy and thermal therapy, and puncture injection of alcohol therapy.

Liver cancer not only has a high incidence rate and is difficult to cure, but is also prone to recurrence after surgery. Therefore, many patients and their families choose percutaneous interventional treatment to improve the patient's quality of life. So, what are the methods of percutaneous interventional treatment for liver cancer?
Skin radiofrequency ablation therapy <br/>This treatment method locates the hepatic artery that supplies blood to the liver cancer lesions and inserts a radiofrequency needle to generate high-frequency radiofrequency waves. The cell tissues around the lesions degenerate and necrotize under high-temperature vibration and friction, thereby blocking the blood supply to the liver cancer site and inhibiting the metastasis of cancer cells.
Hyperthermic perfusion therapy <br/>Hyperthermic perfusion therapy is a treatment method that combines chemotherapy with hyperthermia. Through a puncture needle placed in the patient's chest cavity and connected to a hyperthermia machine, the chemotherapy drugs are heated in vitro and infused into the patient's body. During this period, it is necessary to ensure that the temperature of the drugs reaches and remains at around 40°, so as to kill liver cancer cells and inhibit the disease.
Puncture and injection of alcohol therapy <br/>Puncture and injection of alcohol therapy uses an ultrasound probe to locate liver cancer lesions, and then injects anhydrous alcohol into the lesions while the patient's breathing is stable, successfully inhibiting the spread of liver cancer cells.
I hope the above introduction to percutaneous interventional treatments for liver cancer will be helpful to patients with liver cancer.